Oragenics, Inc.OGENNYSE
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR+104.1%
5Y CAGR-11.6%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+104.1%/yr
vs +0.3%/yr prior
5Y CAGR
-11.6%/yr
Recent acceleration
Acceleration
+103.8pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 36.77% |
| Q2 2025 | 13.89% |
| Q1 2025 | -605.88% |
| Q4 2024 | -34.21% |
| Q3 2024 | 25.49% |
| Q2 2024 | 27.14% |
| Q1 2024 | 85.77% |
| Q4 2023 | -478.82% |
| Q3 2023 | 43.71% |
| Q2 2023 | -7.09% |
| Q1 2023 | -1075.00% |
| Q4 2022 | 93.97% |
| Q3 2022 | 4.33% |
| Q2 2022 | 32.90% |
| Q1 2022 | -158.33% |
| Q4 2021 | 46.90% |
| Q3 2021 | -14.14% |
| Q2 2021 | 34.87% |
| Q1 2021 | 8.43% |
| Q4 2020 | 26.55% |
| Q3 2020 | 68.10% |
| Q2 2020 | -114.70% |
| Q1 2020 | -35.25% |
| Q4 2019 | 2.20% |
| Q3 2019 | 20.16% |
| Q2 2019 | 4.29% |
| Q1 2019 | 13.97% |
| Q4 2018 | 63.86% |
| Q3 2018 | 7.89% |
| Q2 2018 | 9.52% |
| Q1 2018 | -41.65% |
| Q4 2017 | 29.32% |
| Q3 2017 | -69.38% |
| Q2 2017 | 38.54% |
| Q1 2017 | 29.34% |
| Q4 2016 | -42.70% |
| Q3 2016 | -412.39% |
| Q2 2016 | 84.89% |
| Q1 2016 | 14.96% |
| Q4 2015 | -18.74% |